Moumita Gangopadhyay1*, Subhendu Bandyopadhyay2, Sanjukta Dey1 and Arunima Saha1
1School of Life Science and Biotechnology, Department of Biotechnology, Adamas
University, Barasat, Kolkata, India
2School of Life Science and Biotechnology, Department of Biochemistry, Adamas University, Barasat, Kolkata, India
*Corresponding Author: Moumita Gangopadhyay, School of Life Science and Biotechnology, Department of Biotechnology, Adamas University, Barasat, Kolkata, India.
Received: July 01, 2020; Published: July 17, 2020
The sudden outbreak of highly contagious COVID 19 has challenged the existence of Homo sapiens. Although few repurposing old drugs are already used to prevent corona virus but presently, there is no specific promising treatment along with any vaccine for preventing COVID-19. The high infectivity of the causal pathogen SARS-CoV-2 virus combined with high mutation rates has been the greatest hurdle for the scientific societies to discover a potent vaccine or drug for cure which makes the situation even more alarming. Treatment unavailability of this fatal corona virus (COVID 19) has already caused more than 500,000 deaths and the curve is on the rise. Presently, there is no specific treatment for COVID-19 and the coming months will see the greatest public health challenge of this millennium. Development of safe and cheap treatment will prove to be a game changer in the race to move ahead of the curve. The conventional route of vaccine development though seems highly reproducible but not promising in terms of safety issues as the pathogen is highly infectious. In this aspect using Virus-like particles has been a promising vaccine development route for production of a low cost, safe, easy to manufacture and transportable vaccine to protect from novel corona virus (COVID-19). This review work would offer comprehensive fast hand information to medical practitioners and researchers dealing with COVID-19. A brief discussion has done about the ultra-structure of corona virus COVID-19, its systematic position and currently available treatments and their drawbacks. The prospects of vaccine development with their safety efficiency has elaborately discussed. A brief discussion has done on the safe route of vaccine development using Virus-like particles (VLPs) against worldwide COVID-19 pandemic.
Keywords: COVID-19; SARS-CoV-2; Corona Virus; Vaccine; Virus-like Particles
Citation: Moumita Gangopadhyay., et al. “Virus-like Particles (VLPs) based Vaccine Production: A Potentially Safe Candidate Vaccine against Worldwide COVID-19 Pandemic". Acta Scientific Clinical Case Reports 1.7 (2020): 08-13.
Copyright: © 2020 Moumita Gangopadhyay., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.